The recruitment for the ongoing Phase II clinical trial (ClinicalTrials.gov Identifier: NCT04247256) has been updated on clinicaltrials.gov on April 3rd, 2020. As we recently stated in our Q&A (April 2nd, 2020, https://scandiononcology.com/qa/), Scandion Oncology holds no power over clinicaltrials.gov, their data integrity nor processing time of new updates. However, we are pleased that the recruitment status on clinicaltrials.gov has been changed to “Recruiting” and thereby correctly reflects the trial status for recruitment of the study. Recruitment for this ongoing study is open as stated in our latest CEO Newsletter (CEO Newsletter March 2020) and we are in constant contact with our clinical partners to enroll patients.